Status:
COMPLETED
Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
University of California, San Francisco
Conditions:
Liver Transplant
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.
Detailed Description
The Departments of Anesthesiology are conducting an observational trial of markers in the serum of patients who are undergoing liver transplantation surgery. This study will utilize the biological mar...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) Class I-V.
- Patient is undergoing elective Liver Transplant Surgery.
- Patient is an adult, 18 years old or older.
Exclusion
- Patients \< 18 Years of Age
- Patients who are pregnant
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 2 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00698399
Start Date
March 1 2008
End Date
February 2 2010
Last Update
February 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212